NRx Pharmaceuticals Inc.https://investorshangout.com/NRx-Pharmaceuticals-Inc-NRXP-94203/en-usThu, 03 Sep 2026 08:08:28 GMTCopyright InvestorsHangout.comPalpatine: Sharing a free research hub on NRx Pharmaceuticals for the $NRXP board. Excerpt: NRx has a cluster https://investorshangout.com/post/view?id=6838188https://investorshangout.com/post/view?id=6838188Wed, 22 Jul 2026 10:00:07 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Clearance for Depressiohttps://investorshangout.com/post/view?id=6828450https://investorshangout.com/post/view?id=6828450Thu, 07 May 2026 19:36:42 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Initiates First Commercial Manufactuhttps://investorshangout.com/post/view?id=6828117https://investorshangout.com/post/view?id=6828117Tue, 05 May 2026 21:04:16 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives Positive FDA Review Letter https://investorshangout.com/post/view?id=6826005https://investorshangout.com/post/view?id=6826005Wed, 22 Apr 2026 20:15:00 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Supports Executive Order To Accelerahttps://investorshangout.com/post/view?id=6825433https://investorshangout.com/post/view?id=6825433Mon, 20 Apr 2026 20:59:26 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms NRx Defense Systems Subsidiaryhttps://investorshangout.com/post/view?id=6824493https://investorshangout.com/post/view?id=6824493Wed, 15 Apr 2026 20:42:10 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints First Chief Commercial Offihttps://investorshangout.com/post/view?id=6824106https://investorshangout.com/post/view?id=6824106Mon, 13 Apr 2026 20:33:39 GMTNetworkNewsWire: NetworkNewsBreaks – InvestorNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Lahttps://investorshangout.com/post/view?id=6823178https://investorshangout.com/post/view?id=6823178Mon, 06 Apr 2026 21:15:52 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Files 2025 Form 10-K And Highlights https://investorshangout.com/post/view?id=6821376https://investorshangout.com/post/view?id=6821376Tue, 24 Mar 2026 21:06:42 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Feedback On Bioequivalehttps://investorshangout.com/post/view?id=6820365https://investorshangout.com/post/view?id=6820365Tue, 17 Mar 2026 20:38:07 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDAhttps://investorshangout.com/post/view?id=6820196https://investorshangout.com/post/view?id=6820196Mon, 16 Mar 2026 20:57:21 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Guidance Supporting NDAhttps://investorshangout.com/post/view?id=6820195https://investorshangout.com/post/view?id=6820195Mon, 16 Mar 2026 20:57:02 GMTNetworkNewsWire: NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Appoints TMS, Neuroplasticity Researcher Joshua Brown MD,https://investorshangout.com/post/view?id=6819565https://investorshangout.com/post/view?id=6819565Wed, 11 Mar 2026 22:21:13 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Opens Phttps://investorshangout.com/post/view?id=6819169https://investorshangout.com/post/view?id=6819169Mon, 09 Mar 2026 20:51:27 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Appoints Prof. Joshua C. Brown As Chhttps://investorshangout.com/post/view?id=6817935https://investorshangout.com/post/view?id=6817935Mon, 02 Mar 2026 22:15:15 GMTtrooperstocks: $NRXP News: NRx Pharmaceuticals (Nasdaq: NRXP) Appoints Prof. Joshua Brown MD, PhD, as Chief Medihttps://investorshangout.com/post/view?id=6817830https://investorshangout.com/post/view?id=6817830Mon, 02 Mar 2026 12:38:11 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRXhttps://investorshangout.com/post/view?id=6816174https://investorshangout.com/post/view?id=6816174Tue, 17 Feb 2026 20:51:05 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Licenses Real-World Evidence From 70https://investorshangout.com/post/view?id=6811185https://investorshangout.com/post/view?id=6811185Wed, 14 Jan 2026 20:53:18 GMTLee Adams: $NRXP News: NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of https://investorshangout.com/post/view?id=6811107https://investorshangout.com/post/view?id=6811107Wed, 14 Jan 2026 15:56:41 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Eliminates Balance Sheet Debt Throughttps://investorshangout.com/post/view?id=6807722https://investorshangout.com/post/view?id=6807722Thu, 18 Dec 2025 22:06:30 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Amends IND to Advance NRX-101 With Thttps://investorshangout.com/post/view?id=6805075https://investorshangout.com/post/view?id=6805075Wed, 03 Dec 2025 20:29:12 GMTtrooperstocks: $NRXP News: NRx Pharmaceuticals to discuss new NRX-101 pipeline indication for augmentation of Trhttps://investorshangout.com/post/view?id=6804902https://investorshangout.com/post/view?id=6804902Wed, 03 Dec 2025 12:49:17 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Schedules Corporate Update Call for https://investorshangout.com/post/view?id=6804825https://investorshangout.com/post/view?id=6804825Tue, 02 Dec 2025 19:54:51 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces FDA Receipt of ANDA for KEhttps://investorshangout.com/post/view?id=6804824https://investorshangout.com/post/view?id=6804824Tue, 02 Dec 2025 19:52:48 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at NobleCon21 NRx https://investorshangout.com/post/view?id=6804594https://investorshangout.com/post/view?id=6804594Mon, 01 Dec 2025 21:52:42 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q3 Results and Advances NRX-https://investorshangout.com/post/view?id=6802492https://investorshangout.com/post/view?id=6802492Mon, 17 Nov 2025 20:56:52 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Report Q3 2025 Financial Results https://investorshangout.com/post/view?id=6801657https://investorshangout.com/post/view?id=6801657Wed, 12 Nov 2025 20:10:41 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Launches HOPE Therapeutics’ One-Day https://investorshangout.com/post/view?id=6801203https://investorshangout.com/post/view?id=6801203Mon, 10 Nov 2025 20:56:25 GMTNetworkNewsWire: NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Pursues Dual Pathway for Preservative-Free Ketamine-Basedhttps://investorshangout.com/post/view?id=6796784https://investorshangout.com/post/view?id=6796784Thu, 16 Oct 2025 21:21:34 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Advances KETAFREE(TM), Expands Pipelihttps://investorshangout.com/post/view?id=6796770https://investorshangout.com/post/view?id=6796770Thu, 16 Oct 2025 19:41:50 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Present at Noble Capital Markets https://investorshangout.com/post/view?id=6794118https://investorshangout.com/post/view?id=6794118Mon, 06 Oct 2025 20:30:21 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Re-files ANDA for Preservative-Free https://investorshangout.com/post/view?id=6791963https://investorshangout.com/post/view?id=6791963Mon, 29 Sep 2025 20:50:40 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Approval of Suitabilityhttps://investorshangout.com/post/view?id=6790807https://investorshangout.com/post/view?id=6790807Wed, 24 Sep 2025 20:25:06 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics Closes https://investorshangout.com/post/view?id=6787301https://investorshangout.com/post/view?id=6787301Mon, 08 Sep 2025 19:50:48 GMTLee Adams: $NRXP News: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Complete the Acquhttps://investorshangout.com/post/view?id=6787214https://investorshangout.com/post/view?id=6787214Mon, 08 Sep 2025 16:34:28 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) to Join H.C. Wainwright’s 27th Annuahttps://investorshangout.com/post/view?id=6786403https://investorshangout.com/post/view?id=6786403Wed, 03 Sep 2025 20:23:44 GMTNetworkNewsWire: NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Secures FDA Fast Track for IV Ketamine Formulation NRX-10https://investorshangout.com/post/view?id=6786162https://investorshangout.com/post/view?id=6786162Tue, 02 Sep 2025 20:37:25 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Showcases HOPE Therapeutics at Globahttps://investorshangout.com/post/view?id=6786154https://investorshangout.com/post/view?id=6786154Tue, 02 Sep 2025 19:59:48 GMTLee Adams: $NRXP UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Pahttps://investorshangout.com/post/view?id=6786088https://investorshangout.com/post/view?id=6786088Tue, 02 Sep 2025 17:30:36 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Announces Expanded Access Policy forhttps://investorshangout.com/post/view?id=6785097https://investorshangout.com/post/view?id=6785097Wed, 27 Aug 2025 20:10:27 GMTLee Adams: $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Expanded Access Policy for NRX-100 https://investorshangout.com/post/view?id=6784973https://investorshangout.com/post/view?id=6784973Wed, 27 Aug 2025 15:34:27 GMTNetworkNewsWire: NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative - NRxhttps://investorshangout.com/post/view?id=6784114https://investorshangout.com/post/view?id=6784114Fri, 22 Aug 2025 21:35:11 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Reports Q2 2025 Results, Highlights https://investorshangout.com/post/view?id=6782855https://investorshangout.com/post/view?id=6782855Mon, 18 Aug 2025 20:49:46 GMTLee Adams: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on Augusthttps://investorshangout.com/post/view?id=6781595https://investorshangout.com/post/view?id=6781595Tue, 12 Aug 2025 14:26:56 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Receives FDA Fast Track Designation https://investorshangout.com/post/view?id=6781485https://investorshangout.com/post/view?id=6781485Mon, 11 Aug 2025 20:57:03 GMTLee Adams: $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Granted FDA Fast Track Designation for NRX-100 fhttps://investorshangout.com/post/view?id=6781352https://investorshangout.com/post/view?id=6781352Mon, 11 Aug 2025 13:15:34 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Subsidiary HOPE Therapeutics(TM) Sechttps://investorshangout.com/post/view?id=6781161https://investorshangout.com/post/view?id=6781161Fri, 08 Aug 2025 18:49:48 GMTLee Adams: $NRXP News: HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announce Receipt https://investorshangout.com/post/view?id=6781115https://investorshangout.com/post/view?id=6781115Fri, 08 Aug 2025 16:40:14 GMTNetworkNewsWire: NetworkNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chhttps://investorshangout.com/post/view?id=6780372https://investorshangout.com/post/view?id=6780372Mon, 04 Aug 2025 20:19:54 GMTLee Adams: $NRXP News: NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of a Citizen Petition with thttps://investorshangout.com/post/view?id=6780270https://investorshangout.com/post/view?id=6780270Mon, 04 Aug 2025 14:04:06 GMT